Prognostic significance of anatomical resection and des-γ-carboxy prothrombin in patients with hepatocellular carcinoma

被引:195
|
作者
Imamurai, H
Marsuyama, Y
Miyagawa, Y
Ishida, K
Shimada, R
Miyagawa, S
Makuuchi, M
Kawasaki, S
机构
[1] Univ Tokyo, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Sch Hlth Sci & Nursing, Dept Biostat, Tokyo 1138655, Japan
[3] Shinshu Univ, Sch Med, Dept Surg 1, Nagano, Japan
关键词
D O I
10.1046/j.1365-2168.1999.01185.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Portal venous tumour extension and intrahepatic metastasis result in a poor prognosis following hepatectomy for hepatocellular carcinoma (HCC). Anatomical resection is, in theory, preferable for eradicating these types of invasion. Des-gamma-carboxy prothrombin (DCP) has been reported to be associated with adverse pathological variables. This study investigated the significance of anatomical resection and DCP as predictive factors for postoperative recurrence of HCC. Methods: A retrospective cohort study was carried out in 138 consecutive patients who underwent hepatectomy for RCC smaller than 5 cm using the Cox proportional hazards model. Results: Eight factors were univariately related to poor prognosis (in decreasing order of hazard ratio): intrahepatic metastasis, multiple tumours, a-fetoprotein 32ng/ml or more; DCP greater than 0.1 arbitrary units (AU), tumour-exposed surgical margin, vascular invasion, non-anatomical resection and tumour 2.5 cm or more. Three variables (DCP, vascular invasion and tumour-exposed surgical margin) mere excluded by a stepwise procedure in multivariate analysis. Although DCP was not an independent prognostic factor, a model replacing intrahepatic metastasis with DCP showed similar predictive accuracy in a receiver-operating characteristic curve. Conclusion: Anatomical resection appeared to have a beneficial effect on recurrence-free survival after hepatectomy for RCC. DCP measurement was effective in predicting HCC recurrence and had the advantage that it can be assessed before operation.
引用
收藏
页码:1032 / 1038
页数:7
相关论文
共 50 条
  • [31] γ-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-γ-carboxy prothrombin
    Naraki, T
    Kohno, N
    Saito, H
    Fujimoto, Y
    Ohhira, M
    Morita, T
    Kohgo, Y
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1586 (03): : 287 - 298
  • [32] Studies on the correlation among the fucosylation index, concentration of α-fetoprotein and des-γ-carboxy prothrombin as prognostic indicators in hepatocellular carcinoma
    Igarashi, H
    Aoyagi, Y
    Suda, T
    Mita, Y
    Kawai, K
    HEPATOLOGY RESEARCH, 2003, 27 (04) : 279 - 287
  • [33] Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis
    Yang, Ming
    Zhang, Xuejun
    Liu, Jinlong
    PLOS ONE, 2019, 14 (11):
  • [34] The usefulness of determining des-γ-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma
    Mita, Y
    Aoyagi, Y
    Yanagi, M
    Suda, T
    Suzuki, Y
    Asakura, H
    CANCER, 1998, 82 (09) : 1643 - 1648
  • [35] A variant of des-γ-carboxy prothrombin was increased in alcoholic liver disease without hepatocellular carcinoma
    Ohhira, M
    Saito, H
    Suzuki, Y
    Naraki, T
    Sakurai, S
    Ohtake, T
    Suzuki, M
    Ohhira, M
    Fujimoto, Y
    Kohgo, Y
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 25 (06) : 46S - 50S
  • [36] Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma
    Zhang, Yu-Sheng
    Chu, Jia-Hui
    Cui, Shu-Xiang
    Song, Zhi-Yu
    Qu, Xian-Jun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 34 (03) : 903 - 915
  • [37] Des-γ-carboxy Prothrombin in hepatocellular carcinoma post-operative recurrence risk evaluation
    Pan, Xinting
    Zhou, Yang
    Li, Zhenli
    Guo, Pengfei
    Zeng, Jianyang
    Dong, Xiuqing
    Hu, En
    Qiu, Liman
    Cai, Zhixiong
    Chen, Geng
    Liu, Xiaolong
    COMMUNICATIONS MEDICINE, 2025, 5 (01):
  • [38] Early Decrease in α-Fetoprotein, but Not Des-γ-Carboxy Prothrombin, Predicts Sorafenib Efficacy in Patients with Advanced Hepatocellular Carcinoma
    Kuzuya, Teiji
    Asahina, Yasuhiro
    Tsuchiya, Kaoru
    Tanaka, Keisuke
    Suzuki, Yuichiro
    Hoshioka, Takahide
    Tamaki, Shinji
    Kato, Tomoji
    Yasui, Yutaka
    Hosokawa, Takahiro
    Ueda, Ken
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Kurosaki, Masayuki
    Izumi, Namiki
    ONCOLOGY, 2011, 81 (3-4) : 251 - 258
  • [39] Prognosis of Patients with Hepatocellular Carcinoma Treated with TACE: A New Score Combining Alpha-Fetoprotein and Des-γ-Carboxy γ-Carboxy Prothrombin
    Lu, Shang-Yu
    Sun, Han-Yao
    Zhou, Yan
    Luo, Xi
    Liu, Sheng
    Zhou, Wei-Zhong
    Shi, Hai-Bin
    Yang, Wei
    Tian, Wei
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1979 - 1992
  • [40] PROGNOSTIC AND DIAGNOSTIC VALUE OF DES-γ-CARBOXY PROTHROMBIN IN LIVER CANCER
    Bertino, Gaetano
    Ardiri, Annalisa Maria
    Calvagno, Giuseppe Stefano
    Bertino, Nicoletta
    Boemi, Patrizia Maria
    DRUG NEWS & PERSPECTIVES, 2010, 23 (08) : 498 - 508